Biomerica, Inc. (BMRA)
2.142
-0.09
(-4.17%)
USD |
NASDAQ |
Oct 02, 16:00
2.15
+0.01
(+0.37%)
After-Hours: 20:00
Biomerica Gross Profit Margin (Quarterly) : -8.11% for May 31, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -8.11% |
| February 28, 2026 | -4.46% |
| November 30, 2025 | 4.21% |
| August 31, 2025 | 30.72% |
| May 31, 2025 | -32.58% |
| February 28, 2025 | 1.70% |
| November 30, 2024 | 26.71% |
| August 31, 2024 | 15.99% |
| May 31, 2024 | 1.79% |
| February 29, 2024 | -14.65% |
| November 30, 2023 | 20.74% |
| August 31, 2023 | 24.05% |
| May 31, 2023 | 2.60% |
| February 28, 2023 | 10.82% |
| November 30, 2022 | 23.75% |
| August 31, 2022 | -3.36% |
| May 31, 2022 | 11.72% |
| February 28, 2022 | 21.84% |
| November 30, 2021 | 16.61% |
| August 31, 2021 | -7.05% |
| May 31, 2021 | 1.22% |
| February 28, 2021 | -2.02% |
| November 30, 2020 | 22.49% |
| August 31, 2020 | 10.33% |
| May 31, 2020 | 26.92% |
| Date | Value |
|---|---|
| February 29, 2020 | 18.01% |
| November 30, 2019 | 29.37% |
| August 31, 2019 | 30.75% |
| May 31, 2019 | 15.51% |
| February 28, 2019 | 29.01% |
| November 30, 2018 | 27.19% |
| August 31, 2018 | 26.49% |
| May 31, 2018 | 23.74% |
| February 28, 2018 | 33.83% |
| November 30, 2017 | 31.37% |
| August 31, 2017 | 35.62% |
| May 31, 2017 | 30.27% |
| February 28, 2017 | 29.96% |
| November 30, 2016 | 38.87% |
| August 31, 2016 | 40.92% |
| May 31, 2016 | 26.10% |
| February 29, 2016 | 25.30% |
| November 30, 2015 | 35.36% |
| August 31, 2015 | 32.74% |
| May 31, 2015 | 31.16% |
| February 28, 2015 | 35.31% |
| November 30, 2014 | 27.10% |
| August 31, 2014 | 29.96% |
| May 31, 2014 | 34.22% |
| February 28, 2014 | 38.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Univec, Inc. | 9.05% |
| Lantheus Holdings, Inc. | 62.30% |
| Zomedica Corp. | 63.51% |
| IDEXX Laboratories, Inc. | 64.07% |
| Neogen Corp. | 37.59% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -96.10% |
| Return on Assets | -61.95% |
| Return on Invested Capital | -80.89% |
| Profit Margin (Quarterly) | -130.9% |
| Operating Margin (Quarterly) | -175.2% |
| Return on Net Operating Assets | -103.7% |